Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 11;13(1):62.
doi: 10.1007/s12672-022-00490-5.

Immunonutrition reduces complications rate and length of stay after laparoscopic total gastrectomy: a single unit retrospective study

Marzia Franceschilli  1 , Leandro Siragusa  2 , Valeria Usai  2 , Sirvjo Dhimolea  2 , Brunella Pirozzi  2 , Simone Sibio  3 , Sara Di Carlo  2
Affiliations

Immunonutrition reduces complications rate and length of stay after laparoscopic total gastrectomy: a single unit retrospective study

Marzia Franceschilli et al. Discov Oncol. .

Abstract

Background: Preoperative immunonutrition (IN) reduces the incidence of postoperative complications in malnourished patients undergoing upper gastrointestinal surgery. However, its effect in norm-nourished patients remains unclear. Furthermore, patients with gastric cancer undergoing laparoscopic total gastrectomy (LTG) are not routinely included in protocols of enhanced recovery after surgery (ERAS).

Objective: The aim of this study was to investigate the effects of perioperative IN in patients undergoing laparoscopic total gastrectomy (LTG) within an established ERAS pathway.

Methods: A comparative retrospective study of patients undergoing LTG, receiving an immune-enhancing feed plus maltodextrin load the day of surgery (Group A) versus patients who had the same operation but no IN nor fast track management (group B).

Results: There were no significant differences in patient demographic characteristics between the two groups but the medium age of patients in group A was older. Thirty-days postoperative complications were respectively 8.7% in Group A and 33.3% in Group B (p 0.04). Mean and median LOS for Group A and B were also significantly different: 7.2 ± 4.4 vs 10.3 ± 5.4 and 7 vs 10 days respectively.

Conclusion: Preoperative IN associated with ERAS protocol in normo-nourished patient undergoing LTG seems to reduce postoperative complications. Reduction in LOS is possibly associated to the ERAS protocol. Clinical trial registration Clinical trials.gov: NCT05259488.

Keywords: Gastric cancer; Immunonutrition; Laparoscopy; Total gastrectomy; Upper GI surgery.

PubMed Disclaimer

Conflict of interest statement

This research didn’t received grants from any founding agency in public, commercial or not-for-profit sectors.

Figures

Fig. 1
Fig. 1
Summary of ERAS features
Fig. 2
Fig. 2
Patient selection
See this image and copyright information in PMC

References

    1. Amelio I, Bertolo R, Bove P, Buonomo O, Candi E, et al. Liquid biopsies and cancer omics. Cell Death Discov. 2020;6(1):131. doi: 10.1038/s41420-020-00373-0. - DOI - PMC - PubMed
    1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. doi: 10.3322/caac.21492. - DOI - PubMed
    1. Mortensen K, Nilsson M, Slim K, Schäfer M, Mariette C, Braga M, Carli F, Demartines N, Griffin SM, Lassen K, Enhanced Recovery After Surgery (ERAS®) Group Consensus guidelines for enhanced recovery after gastrectomy: enhanced recovery after surgery (ERAS®) society recommendations. Br J Surg. 2014;101(10):1209–1229. doi: 10.1002/bjs.9582. - DOI - PubMed
    1. Ljungqvist O, Scott M, Fearon KC. Enhanced recovery after surgery. JAMA Surg. 2017 doi: 10.1001/jamasurg.2016.4952. - DOI - PubMed
    1. Fina D, Franzè E, Rovedatti L, Corazza GR, Biancone L, Sileri PP, Sica G, MacDonald TT, Pallone F, Di Sabatino A, Monteleone G. Interleukin-25 production is differently regulated by TNF-alpha and TGF-beta 1 in the human gut. Mucosal Immunol. 2014;4(2):239–244. doi: 10.1038/mi.2010.68. - DOI - PubMed

Associated data

LinkOut - more resources